generic partners uk ltd
generic partners uk ltd Company Information
Company Number
08202030
Website
www.genericpartners.comRegistered Address
unit 4 metro centre, tolpits lane, watford, WD18 9SS
Industry
Wholesale of pharmaceutical goods
Telephone
-
Next Accounts Due
December 2024
Group Structure
View All
Shareholders
strides phama global p.t.e. limited 100%
generic partners uk ltd Estimated Valuation
Pomanda estimates the enterprise value of GENERIC PARTNERS UK LTD at £351.2k based on a Turnover of £644.7k and 0.54x industry multiple (adjusted for size and gross margin).
generic partners uk ltd Estimated Valuation
Pomanda estimates the enterprise value of GENERIC PARTNERS UK LTD at £0 based on an EBITDA of £-412.4k and a 3.95x industry multiple (adjusted for size and gross margin).
generic partners uk ltd Estimated Valuation
Pomanda estimates the enterprise value of GENERIC PARTNERS UK LTD at £0 based on Net Assets of £-11.7k and 2.06x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Generic Partners Uk Ltd Overview
Generic Partners Uk Ltd is a live company located in watford, WD18 9SS with a Companies House number of 08202030. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in September 2012, it's largest shareholder is strides phama global p.t.e. limited with a 100% stake. Generic Partners Uk Ltd is a established, small sized company, Pomanda has estimated its turnover at £644.7k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Generic Partners Uk Ltd Health Check
Pomanda's financial health check has awarded Generic Partners Uk Ltd a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 4 areas for improvement. Company Health Check FAQs
2 Strong
3 Regular
4 Weak
Size
annual sales of £644.7k, make it smaller than the average company (£26.1m)
- Generic Partners Uk Ltd
£26.1m - Industry AVG
Growth
3 year (CAGR) sales growth of 9%, show it is growing at a faster rate (4.8%)
- Generic Partners Uk Ltd
4.8% - Industry AVG
Production
with a gross margin of 23.5%, this company has a comparable cost of product (23.5%)
- Generic Partners Uk Ltd
23.5% - Industry AVG
Profitability
an operating margin of -64% make it less profitable than the average company (3.6%)
- Generic Partners Uk Ltd
3.6% - Industry AVG
Employees
with 1 employees, this is below the industry average (39)
1 - Generic Partners Uk Ltd
39 - Industry AVG
Pay Structure
on an average salary of £66.2k, the company has an equivalent pay structure (£66.2k)
- Generic Partners Uk Ltd
£66.2k - Industry AVG
Efficiency
resulting in sales per employee of £644.7k, this is equally as efficient (£644.7k)
- Generic Partners Uk Ltd
£644.7k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Generic Partners Uk Ltd
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Generic Partners Uk Ltd
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Generic Partners Uk Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 21 weeks, this is more cash available to meet short term requirements (9 weeks)
21 weeks - Generic Partners Uk Ltd
9 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 238.6%, this is a higher level of debt than the average (57.1%)
238.6% - Generic Partners Uk Ltd
57.1% - Industry AVG
GENERIC PARTNERS UK LTD financials
Generic Partners Uk Ltd's latest turnover from March 2023 is estimated at £644.7 thousand and the company has net assets of -£11.7 thousand. According to their latest financial statements, Generic Partners Uk Ltd has 1 employee and maintains cash reserves of £8.4 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||
| Other Income Or Grants | |||||||||||
| Cost Of Sales | |||||||||||
| Gross Profit | |||||||||||
| Admin Expenses | |||||||||||
| Operating Profit | |||||||||||
| Interest Payable | |||||||||||
| Interest Receivable | |||||||||||
| Pre-Tax Profit | |||||||||||
| Tax | |||||||||||
| Profit After Tax | |||||||||||
| Dividends Paid | |||||||||||
| Retained Profit | |||||||||||
| Employee Costs | |||||||||||
| Number Of Employees | 1 | 1 | 3 | 2 | |||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 2,398 | 3,197 | 2,494 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 394,524 | 329,565 | 172,482 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 627,910 | 494,182 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 394,524 | 329,565 | 174,880 | 3,197 | 630,404 | 494,182 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 381,797 | 152,121 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 14,348 | 5,879 | 234,164 | 1,253,098 | 671,170 | 279,092 | 440,606 | 249,891 |
| Group Debtors | 0 | 390,893 | 401,646 | 408,791 | 130,808 | 0 | 17,820 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 6,753 | 4,963 | 2,992 | 67,084 | 95,136 | 58,600 | 74,543 | 0 | 0 | 0 |
| Cash | 8,436 | 35,177 | 35,187 | 35,187 | 134,770 | 210,750 | 40,599 | 31,600 | 85,742 | 46,080 | 32,254 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 955,290 | 0 | 0 | 0 |
| total current assets | 8,436 | 432,823 | 441,796 | 461,318 | 338,541 | 540,050 | 1,751,914 | 1,884,724 | 364,834 | 486,686 | 282,145 |
| total assets | 8,436 | 432,823 | 441,796 | 461,318 | 733,065 | 869,615 | 1,926,794 | 1,887,921 | 995,238 | 980,868 | 282,145 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 81,536 | 143,097 | 877,733 | 782,539 | 1,321,504 | 965,424 | 302,464 |
| Group/Directors Accounts | 7,573 | 7,262 | 7,337 | 0 | 0 | 9,948 | 531,506 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 12,555 | 25,731 | 7,210 | 9,760 | 18,609 | 79,353 | 41,882 | 68,766 | 0 | 0 | 0 |
| total current liabilities | 20,128 | 32,993 | 14,547 | 9,760 | 100,145 | 232,398 | 1,451,121 | 851,305 | 1,321,504 | 965,424 | 302,464 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 20,128 | 32,993 | 14,547 | 9,760 | 100,145 | 232,398 | 1,451,121 | 851,305 | 1,321,504 | 965,424 | 302,464 |
| net assets | -11,692 | 399,830 | 427,249 | 451,558 | 632,920 | 637,217 | 475,673 | 1,036,616 | -326,266 | 15,444 | -20,319 |
| total shareholders funds | -11,692 | 399,830 | 427,249 | 451,558 | 632,920 | 637,217 | 475,673 | 1,036,616 | -326,266 | 15,444 | -20,319 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||
| Operating Profit | |||||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 149 | 1,065 | 829 | 0 | 0 | |
| Amortisation | 0 | 0 | 0 | 119 | 158 | 0 | 0 | 0 | 0 | 0 | |
| Tax | |||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | -381,797 | 229,676 | 152,121 | 0 | 0 | 0 |
| Debtors | -397,646 | -8,963 | -19,522 | 222,360 | -125,529 | -1,000,218 | 583,805 | 466,621 | -161,514 | 190,715 | 249,891 |
| Creditors | 0 | 0 | 0 | -81,536 | -61,561 | -734,636 | 95,194 | -538,965 | 356,080 | 662,960 | 302,464 |
| Accruals and Deferred Income | -13,176 | 18,521 | -2,550 | -8,849 | -60,744 | 37,471 | -26,884 | 68,766 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||||||
| Investing Activities | |||||||||||
| capital expenditure | |||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -627,910 | 133,728 | 494,182 | 0 |
| cash flow from investments | |||||||||||
| Financing Activities | |||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 311 | -75 | 7,337 | 0 | -9,948 | -521,558 | 531,506 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||
| interest | |||||||||||
| cash flow from financing | |||||||||||
| cash and cash equivalents | |||||||||||
| cash | -26,741 | -10 | 0 | -99,583 | -75,980 | 170,151 | 8,999 | -54,142 | 39,662 | 13,826 | 32,254 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -26,741 | -10 | 0 | -99,583 | -75,980 | 170,151 | 8,999 | -54,142 | 39,662 | 13,826 | 32,254 |
generic partners uk ltd Credit Report and Business Information
Generic Partners Uk Ltd Competitor Analysis
Perform a competitor analysis for generic partners uk ltd by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in WD18 area or any other competitors across 12 key performance metrics.
generic partners uk ltd Ownership
GENERIC PARTNERS UK LTD group structure
Generic Partners Uk Ltd has no subsidiary companies.
Ultimate parent company
STRIDES PHARMA SCIENCE LTD
#0097439
STRIDES PHARMA GLOBAL PTE LTD
#0112694
2 parents
GENERIC PARTNERS UK LTD
08202030
generic partners uk ltd directors
Generic Partners Uk Ltd currently has 2 directors. The longest serving directors include Mr Visvanathan Rajasekar (Jun 2021) and Mr Visvanathan Rajasekar (Jun 2021).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Visvanathan Rajasekar | United Kingdom | 63 years | Jun 2021 | - | Director |
| Mr Visvanathan Rajasekar | England | 63 years | Jun 2021 | - | Director |
P&L
March 2023turnover
644.7k
+1%
operating profit
-412.4k
0%
gross margin
23.5%
+2.96%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
-11.7k
-1.03%
total assets
8.4k
-0.98%
cash
8.4k
-0.76%
net assets
Total assets minus all liabilities
generic partners uk ltd company details
company number
08202030
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
September 2012
age
12
incorporated
UK
accounts
Small Company
ultimate parent company
previous names
N/A
last accounts submitted
March 2023
address
unit 4 metro centre, tolpits lane, watford, WD18 9SS
accountant
MHA
auditor
-
generic partners uk ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to generic partners uk ltd.
generic partners uk ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
